Z. ZHAO, X. HU, Y. ZHANG, and D. LIU, “Cardiovascular and safety events of PCSK9 inhibitors in statin-treated patients with cardiovascular risk: A Systematic Review and Meta-Analysis”, J Pharm Pharm Sci, vol. 23, pp. 422–436, Oct. 2020.